The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1021
February 27, 1998
View Complete Issue         Table of Contents 2019 
Propecia and Rogaine Extra Strength for Alopecia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Propecia and Rogaine Extra Strength for Alopecia
February 27, 1998 (Issue: 1021)
Two new formulations of existing drugs were recently approved by the FDA for treatment of male androgenetic alopecia. Finasteride, a steroid 5alpha-reductase inhibitor previously marketed in a 5-mg tablet as Proscar for treatment of benign prostatic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Propecia and Rogaine Extra Strength for Alopecia
Article code: 1021a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.